Clinical Trials

Clinical trials are the key to medical progress. Through clinical trials, researchers test new ways to detect, treat and prevent Alzheimer's disease and related dementias. Without clinical trials, there can be no new treatments or cures.

Ground-breaking research is going on that could have a measurable impact on the lives of current and future Alzheimer's patients. But a lack of volunteers for Alzheimer's disease clinical trials is significantly slowing down this research and the development of new Alzheimer's disease treatments. Recruiting and retaining trial participants is now the greatest obstacle, other than funding, to developing the next generation of Alzheimer's disease treatments.

Please visit How can I learn more about clinical trials?

For more information about Alzheimer's disease and related clinical trials, please visit the following web sites: The Alzheimer's Association TrialMatch, CenterWatch and The National Institute on Aging

For more information about research, please visit the following web sites and/or reports:

This report details the National Institutes of Health (NIH) supported and conducted Alzheimer's disease research initiatives, objectives, and advances during calendar year 2014 and early 2015. New findings and investments described in this report are organized in categories determined by the Common Alzheimer Disease Research Ontology (CADRO) of the International Alzheimer's Disease Research Portfolio (IADRP).

The NIH-supported IADRP database, developed in collaboration with the Alzheimer's Association, captures a wide spectrum of current Alzheimer's disease and other dementias research investments and resources in the United States and internationally. The CADRO categories, which have informed the goals and objectives set forth in the National Plan to Address Alzheimer's disease, have proven useful in tracking spending in specific areas of research, making the categories an ideal structure for reporting on scientific advances.